Literature DB >> 26307531

Intramuscular phosphagen status and the relationship to muscle performance across the age spectrum.

Chad M Kerksick1, Michael D Roberts2, Vincent J Dalbo3, Kyle L Sunderland4.   

Abstract

PURPOSE: To examine age-related differences in intramuscular concentrations of adenosine triphosphate (ATP), free creatine (FCr), phosphocreatine (PCr) and total creatine (TCr) and if these differences were related to muscle performance.
METHODS: Forty-two healthy, non-sedentary, males between 20 and 76 years provided muscle samples to determine [ATP], [FCr], [PCr], and [TCr]. Maximal strength and endurance were assessed and correlated with intramuscular variables.
RESULTS: Intramuscular [ATP] decreased by 13.5% (p = 0.013) in the older cohort (18.0 ± 0.6 mmol/kg dry wt) vs. the young cohort (20.8 ± 0.9 mmol/kg dry wt) and was significantly correlated to age (r = -0.38, p = 0.008). No other differences were observed between age groups for intramuscular [PCr], [FCr], [TCr], or [PCr]:[TCr] (p > 0.05). The older cohort consumed significantly less (p < 0.05) dietary protein when compared to the young cohort. Bivariate correlations were found for intramuscular [ATP] and lower body 1RM (r = 0.24, p = 0.066), leg press volume and free creatine (r = 0.325, p = 0.036) and leg press repetitions and free creatine (r = 0.373, p = 0.015). Partial correlations controlling for age eliminated the relationship between [ATP] and 1RM while intramuscular free creatine and leg press repetitions remained significant (p < 0.05) and leg press volume approached significance (p = 0.095).
CONCLUSION: These results expand upon previous observations indicative of age-related reductions in intramuscular [ATP] and dietary protein intake. The lack of change in other intramuscular PCr system markers are suggestive of dysfunctions at the mitochondrial level while the impact of neuromuscular changes, lean mass cross-sectional area and differences in physical activity are also important.

Entities:  

Keywords:  ATP; Aging; Muscle strength; Phosphocreatine

Mesh:

Substances:

Year:  2015        PMID: 26307531     DOI: 10.1007/s00421-015-3246-1

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  37 in total

Review 1.  [Aging and physical activity data on which to base recommendations for exercise in older adults].

Authors:  Donald H Paterson; Gareth R Jones; Charles L Rice
Journal:  Appl Physiol Nutr Metab       Date:  2007       Impact factor: 2.665

2.  Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.

Authors:  M A Tarnopolsky; G Parise
Journal:  Muscle Nerve       Date:  1999-09       Impact factor: 3.217

3.  Increase in percutaneous muscle biopsy yield with a suction-enhancement technique.

Authors:  J V Hennessey; J A Chromiak; S Della Ventura; J Guertin; D B MacLean
Journal:  J Appl Physiol (1985)       Date:  1997-06

4.  Decline in skeletal muscle mitochondrial function with aging in humans.

Authors:  Kevin R Short; Maureen L Bigelow; Jane Kahl; Ravinder Singh; Jill Coenen-Schimke; Sreekumar Raghavakaimal; K Sreekumaran Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

Review 5.  Dietary protein and muscle in older persons.

Authors:  Douglas Paddon-Jones; Heather Leidy
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-01       Impact factor: 4.294

6.  Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity.

Authors:  Kevin R Short; Janet L Vittone; Maureen L Bigelow; David N Proctor; Robert A Rizza; Jill M Coenen-Schimke; K Sreekumaran Nair
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

7.  Effect of aging on energy-rich phosphagens in human skeletal muscles.

Authors:  P Möller; J Bergström; P Fürst; K Hellström
Journal:  Clin Sci (Lond)       Date:  1980-06       Impact factor: 6.124

8.  Clinical value of anthropometric estimates of leg lean volume in nutritionally depleted and non-depleted patients with chronic obstructive pulmonary disease.

Authors:  Débora Strose Villaça; Maria Cristina Lerario; Simone dal Corso; Lara Nápolis; André Luiz Pereira de Albuquerque; Marize Lazaretti-Castro; Anita Sachs; Luiz Eduardo Nery; Jose Alberto Neder
Journal:  Br J Nutr       Date:  2008-01-10       Impact factor: 3.718

9.  The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults.

Authors:  Vincent J Dalbo; Michael D Roberts; Chris M Lockwood; Patrick S Tucker; Richard B Kreider; Chad M Kerksick
Journal:  Dyn Med       Date:  2009-12-24

10.  Mitochondrial energetics is impaired in vivo in aged skeletal muscle.

Authors:  Gilles Gouspillou; Isabelle Bourdel-Marchasson; Richard Rouland; Guillaume Calmettes; Marc Biran; Véronique Deschodt-Arsac; Sylvain Miraux; Eric Thiaudiere; Philippe Pasdois; Dominique Detaille; Jean-Michel Franconi; Marion Babot; Véronique Trézéguet; Laurent Arsac; Philippe Diolez
Journal:  Aging Cell       Date:  2013-09-19       Impact factor: 9.304

View more
  4 in total

1. 

Authors:  Jelena Gacesa
Journal:  Sports Med Int Open       Date:  2017-01-31

2.  Maximal aerobic power and anaerobic capacity in cycling across the age spectrum in male master athletes.

Authors:  C Capelli; J Rittveger; P Bruseghini; E Calabria; E Tam
Journal:  Eur J Appl Physiol       Date:  2016-05-25       Impact factor: 3.078

3.  Aging in Rats Differentially Affects Markers of Transcriptional and Translational Capacity in Soleus and Plantaris Muscle.

Authors:  Christopher B Mobley; Petey W Mumford; Wesley C Kephart; Cody T Haun; Angelia M Holland; Darren T Beck; Jeffrey S Martin; Kaelin C Young; Richard G Anderson; Romil K Patel; Gillis L Langston; Ryan P Lowery; Jacob M Wilson; Michael D Roberts
Journal:  Front Physiol       Date:  2017-07-20       Impact factor: 4.566

Review 4.  Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy.

Authors:  Spencer G Miller; Paul S Hafen; Jeffrey J Brault
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.